Cerebral proteome adaptations to amyloid angiopathy are prevented by carbonic anhydrase inhibitors

Ähnliche Einträge

• Carbonic anhydrase inhibitors prevent presymptomatic capillary flow disturbances in a model of cerebral amyloidosis
  von: Eugenio Gutiérrez‐Jiménez, et al.
  Veröffentlicht: (2025)
• Cerebral amyloid angiopathy and the immune system
  von: Danielle Munsterman, et al.
  Veröffentlicht: (2024)
• Circulating proteomic biomarkers for cerebral amyloid angiopathy screening and risk stratification
  von: Jiajie Xu, et al.
  Veröffentlicht: (2025)
• Carbonic anhydrase inhibitors (CAIs) decrease cardiac amyloid β pathology, mitigating neuro‐signaling maladaptive remodeling and improving cardiac function in Tg2676‐ AD mouse model
  von: Andrea Elia, et al.
  Veröffentlicht: (2024)
• Pathological amyloid β and tau induce a metabolic switch in cerebral endothelial cells: implications for blood brain barrier dysfunction and perivascular inflammation
  von: Silvia Fossati
  Veröffentlicht: (2025)